Showing results (171-180 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|January 27, 2018
Bayesian dose-finding phase I trial design incorporating historical data from a preceding trialKentaro Takeda, Satoshi MoritaPharmaceutical Statistics|August 26, 2017
Adaptive phase I/II clinical trials for drug combination assessment in oncology using the outcomes of each cycleShinjo Yada, Chikuma HamadaPharmaceutical Statistics|May 10, 2022
A Bayesian latent class model for predicting gestational age in health administrative dataShuang Wang, Gavino Puggioni, Xuerong WenPharmaceutical Statistics|June 4, 2021
Bayesian single-arm phase II trial designs with time-to-event endpointsJianrong Wu, Haitao Pan, Chia-Wei HsuPharmaceutical Statistics|June 2, 2021
Mitigation of the convergence issues associated with semi-replicated bioequivalence dataAnders FuglsangPharmaceutical Statistics|March 1, 2020
Simultaneous confidence interval for assessing non-inferiority with assay sensitivity in a three-arm trial with binary endpointsNiansheng Tang, Bin YuPharmaceutical Statistics|April 6, 2020
Bayesian adaptive linearization method for phase I drug combination trials with dimension reductionHaitao Pan, Cheng Cheng, Ying YuanPharmaceutical Statistics|December 22, 2020
Non-proportional hazards in immuno-oncology: Is an old perspective needed?Dominic MagirrPharmaceutical Statistics|September 26, 2022
A Bayesian phase I/II design to determine subgroup-specific optimal dose for immunotherapy sequentially combined with radiotherapyBeibei Guo, Yong Zang, Li-Hsiang Lin, et al.Pageof 119